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Brain-derived neurotrophic factor (BDNF) is a potent regulator of neuronal development
and synaptic plasticity that is fundamental to neural circuit formation and cognition. It is
also involved in the control of appetite and body weight, with mutations in the genes
for BDNF and its receptor, TrkB, resulting in remarkable hyperphagia and severe obesity
in humans and mice. Recent studies have made significant progress in elucidating the
source, action sites, and regulatory pathways of BDNF with regard to its role in the control
of energy homeostasis, and have shed light on the relationships between BDNF and
other molecules involved in the control of body weight. Here we provide a comprehensive
review of evidence from pharmacological, genetic, and mechanistic studies, linking BDNF
to the control of body weight. This review also aims to organize the main findings on
this subject into a more refined framework and to discuss the future research directions
necessary to advance the field.
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INTRODUCTION
Brain-derived neurotrophic factor (BDNF) is a member of
the neurotrophin family of secreted signaling molecules that
includes nerve growth factor (NGF), neurotrophin-3 (NT3),
and neurotrophin-4/5 (NT4/5). Signal transduction can occur
through the binding of two distinct classes of receptor pro-
teins: the tropomyosin receptor kinase (Trk) family of recep-
tor tyrosine kinases, which includes TrkA, TrkB, and TrkC, or
the p75 neurotrophin receptor (p75NTR). The Trk receptors
have different neurotrophins as their preferred ligands, with
NGF binding to TrkA, BDNF and NT4/5 binding to TrkB and
NT3 binding to TrkC, while all of the neurotrophins can bind
to p75NTR (Barbacid, 1994; Bibel and Barde, 2000; Reichardt,
2006). Neurotrophins are expressed both during development
and throughout adulthood (Hofer et al., 1990; Yan et al., 1997b).
They play crucial roles both in the proper wiring of neural circuits
and in the modulation of connections in the mature nervous sys-
tem by influencing neuronal survival and differentiation as well
as synapse formation and plasticity (Chao, 2003; Waterhouse and
Xu, 2009).
Perturbation of normal BDNF levels has been associated with
many disease states, including Alzheimer’s disease, Parkinson’s
disease, Huntington’s disease, schizophrenia, and depression
(Teixeira et al., 2010; Diniz and Teixeira, 2011; Satomura et al.,
2011). Recent genetic data has also linked deficiencies in TrkB
signaling to obesity (Rios et al., 2001; Xu et al., 2003; Yeo et al.,
2004).
A key molecule involved in the control of body weight is lep-
tin, which is the protein product of the ob gene and is produced
and secreted from adipose tissue, and serves as an indicator of
fat mass (Zhang et al., 1994; Elmquist et al., 1998). Its expression
and secretion was found to be increased after either food intake or
insulin injection, indicating that in addition to serving as a mea-
sure of adiposity, leptin levels can be modulated by nutritional
status, probably through changes in insulin release regulated by
blood glucose levels (Saladin et al., 1995; Barr et al., 1997; Boden
et al., 1997). Treatment with leptin can lead to reduced fat stor-
age through reduction in food intake as well as by increasing
energy expenditure (Hamann and Matthaei, 1996; Stehling et al.,
1996). In addition to leptin, many other factors have been shown
to regulate energy balance, including insulin produced in the
pancreas (Woods et al., 1979), glucagon-like-polypeptide-1 pro-
duced in the ileum (Tang-Christensen et al., 1996; Turton et al.,
1996), peptide tyrosine tyrosine produced in the terminal ileum
and colon (Batterham et al., 2002), cholecystokinin (CCK) pro-
duced in the duodenum (Dockray, 2012), ghrelin produced in
the stomach (Kojima et al., 1999; Nakazato et al., 2001), and var-
ious metabolites such as glucose, fatty acids, and amino acids
(Loftus et al., 2000; Cota et al., 2006; He et al., 2006; Pocai et al.,
2006).
These peripheral factors reach the brain via the circulatory
system and are integrated in several brain regions, including the
arcuate nucleus (ARC), dorsomedial hypothalamus (DMH), ven-
tromedial hypothalamus (VMH), paraventricular hypothalamus
(PVH), and brainstem (Flier, 2004; Morton et al., 2006). The
ARC is a hypothalamic nucleus with a well-demonstrated role
in responding to peripheral signals of nutritional status, such as
leptin, to regulate energy balance (Coppari et al., 2005). There
are two distinct populations of neurons in the ARC involved
in mediating this response: one that co-expresses proopiome-
lanocortin (POMC) and cocaine- and amphetamine-regulated
transcript (CART), while the other co-expresses agouti-related
protein (AgRP) and neuropeptide Y (NPY) (Parker and Bloom,
2012). One metabolite of POMC, alpha melanocyte-stimulating
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hormone (α-MSH), is an agonist of the melanocortin 4 recep-
tor (MC4R). Conversely, AgRP is an inverse agonist of the MC4R
(Ollmann et al., 1997). Furthermore, NPY can activate its recep-
tors on POMC neurons in the ARC to induce hyperpolarization
and decrease excitability (Cowley et al., 2001). Both populations
express the leptin receptor, with signaling in POMC/CART neu-
rons leading to increased secretion of α-MSH and activation of
anorexigenic pathways, while signaling in AgRP/NPY neurons
results in decreased secretion of AgRP and NPY and relief of
inhibition of these pathways (Ellacott and Cone, 2006; Williams
et al., 2011). POMC neurons in the ARC receive strong excitatory
input from the medial VMH, which is decreased during fasting.
NPY neurons in the ARC only receive weak inhibitory input from
within the ARC itself (Sternson et al., 2005).
THE Bdnf GENE AND ITS EXPRESSION
The mouse and rat Bdnf genes have nine exons, the first eight of
which contain 5′ untranslated regions (5′ UTRs), with exon IX
containing the entire coding sequence as well as the 3′ untrans-
lated region (3′ UTR) (Timmusk et al., 1993; Aid et al., 2007).
Transcription can be initiated at any of the eight untranslated
exons, which are spliced to the common coding exon IX, gen-
erating mRNA species with different 5′ UTRs that code for the
same protein. The number of potential transcripts is further
increased by polyadenylation at either of two sites, one 350 bases
downstream of the stop codon and the other at 2.85 kb down-
stream. Although the various transcripts encode the same protein,
they are expressed differentially throughout development, have
distinct spatial expression patterns, and respond uniquely to stim-
ulation. Synthesis of some of these transcripts is regulated by
the activity of the cyclic AMP responsive element binding pro-
tein (CREB) and methyl CpG-binding protein 2 (Tao et al.,
1998; Chen et al., 2003). Recent studies investigating the rela-
tive importance of Bdnf mRNA sequences in directing mRNA
trafficking have led to conflicting reports of which regions are
involved, with work in our laboratory demonstrating a critical
role for the long Bdnf 3′ UTR in directing dendritic trafficking
(An et al., 2008), while another lab has shown the importance of
coding and 5′ UTR sequences (Chiaruttini et al., 2009; Baj et al.,
2011). The various temporal, spatial and activity-dependent pat-
terns of transcription for the different Bdnf mRNA species allows
for highly specific and fine-tuned regulation of BDNF synthesis,
which can be further refined by post-transcriptional regulatory
mechanisms acting on RNA transcript stability and translational
activation.
Bdnf mRNA has been detected in many brain regions, includ-
ing the cortex, hippocampus, amygdala, DMH, PVH, VMH,
lateral hypothalamus (LH), ventral tegmental area (VTA), sub-
stantia nigra and nucleus of the solitary tract (NTS) (Conner
et al., 1997; Xu et al., 2003). BDNF immunoreactive fibers, indi-
cating possible sites of BDNF/TrkB signaling, were found in the
cortex, hippocampus, nucleus accumbens (NAc), amygdala, ARC,
DMH, LH, PVH, VMH, VTA, substantia nigra, dorsal raphe
nucleus, and NTS (Conner et al., 1997; Katoh-Semba et al.,
1997; Yan et al., 1997b). TrkB in the adult rat brain has been
localized to the olfactory system, cortex, hippocampus, most
nuclei of the hypothalamus, striatum, amygdala, septal nuclei,
substantia nigra, cerebellar Purkinje cells, brainstem and spinal
motor neurons, and brainstem sensory nuclei (Masana et al.,
1993; Yan et al., 1997a; Kernie et al., 2000; Xu et al., 2003).
Interestingly, not all areas that express TrkB are also sites of
BDNF synthesis, though they may contain BDNF-positive fibers,
a pattern seen in the striatum and ARC (Altar et al., 1997; Xu
et al., 2003; Baydyuk et al., 2011b), indicating these areas as sites
of anterograde or retrograde BDNF action, with BDNF originat-
ing from distal brain regions. In the areas that express both BDNF
and TrkB, autocrine or paracrine signaling is also possible, with
TrkB activation occurring from binding of BDNF released from
the same or neighboring cells.
SECRETION AND SIGNALING OF BDNF
BDNF is initially synthesized as a pre-pro-neurotrophin, contain-
ing a signal peptide directing sequestration of the nascent protein
to the endoplasmic reticulum (ER), after which the signal pep-
tide is cleaved, leaving proBDNF (Halban and Irminger, 1994).
ProBDNF then traffics through the Golgi apparatus where it can
be sorted into two different types of secretory granules, small vesi-
cles that fuse to the plasma membrane and release their contents
constitutively, or larger vesicles whose fusion to the plasma mem-
brane is regulated and depends on Ca2+ levels (Lessmann et al.,
2003). Intracellular cleavage of proBDNF to generate mature
BDNF (mBDNF) was observed in hippocampal neurons (Mowla
et al., 1999), and for a time it was believed that only secreted
mBDNF was biologically active. Recent work has demonstrated
that tissue plasminogen activator (tPA), a secretory protein impli-
cated in the late phase of long-term potentiation (L-LTP), can
lead to cleavage of secreted proBDNF to mBDNF by activation of
plasmin, an extracellular protease (Pang et al., 2004; Yang et al.,
2009). Furthermore, secretion of proBDNF is biologically rele-
vant, as its binding to p75NTR can lead to cell death and long-term
depression (Teng et al., 2005; Woo et al., 2005).
BDNF functions as a homodimer that can bind to and dimer-
ize TrkB receptors, leading to their transphosphorylation on tyro-
sine residues located in their intracellular domains (Patapoutian
and Reichardt, 2001). This event triggers three different signaling
cascades through activation of mitogen-activated protein kinase
(MAPK), phosphatidylinositol 3-kinase (PI3K) and phospholi-
pase C-gamma (PLCγ). The MAPK pathway regulates neuronal
differentiation and maturation, while the PI3K pathway is essen-
tial for neuronal survival (Reichardt, 2006). In addition, signaling
through the MAPK pathway leads to activation of CREB and
upregulation of its target genes, as well as phosphorylation of
eukaryotic initiation factor 4E (eIF4E), 4E-binding protein 1
(4E-BP1) and ribosomal protein S6, playing an important role
in the regulation of protein synthesis-dependent synaptic plastic-
ity. The PI3K pathway also is an important regulator of synaptic
protein synthesis and trafficking through the activation of Akt
and the mammalian target of rapamycin (mTOR), which can
phosphorylate 4E-BP1 to enhance translation (Bramham and
Wells, 2007). Activation of the PLCγ pathway leads to produc-
tion of diacylglycerol (DAG), which can activate PKC, and inositol
1,4,5-triphosphate (IP3), which leads to the release of intracellu-
lar Ca2+ stores, resulting in enhancement of synaptic plasticity
(Reichardt, 2006).
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EVIDENCE FOR A CRITICAL ROLE OF BDNF IN ENERGY
HOMEOSTASIS
BDNF was first found to reduce body weight of adult rats in a
study that was designed to examine the effect of chronic intrac-
erebroventricular (icv) infusion of neurotrophins on presynaptic
cholinergic function (Lapchak and Hefti, 1992). A subsequent
study found that chronic injection of BDNF to the lateral ven-
tricle of rats resulted in decreased food intake, leading to loss
of body weight (Pelleymounter et al., 1995). A critical role for
endogenous BDNF in the regulation of feeding behavior was
demonstrated in mice with reduced BDNF levels, such as het-
erozygous BDNF (Bdnf +/−) mice, which had increased risk of
obesity resulting from increased food intake, concomitant with
elevated serum leptin and insulin levels (Lyons et al., 1999; Kernie
et al., 2000). This genetic finding was confirmed and extended
by the severe obesity phenotypes observed in mice expressing the
TrkB receptor at ∼25% of normal levels (Xu et al., 2003) and
in mice where the Bdnf gene is deleted in neurons expressing
Ca2+/calmodulin-dependent protein kinase II alpha (CaMKIIα)
(Rios et al., 2001). Since CaMKIIα is a brain-specific protein (Lin
et al., 1987), this observation demonstrates that BDNF acts on
neurons of the central nervous system to affect energy balance.
Deficiencies in BDNF signaling are also associated with obe-
sity in humans. A de novo missense mutation in a key tyrosine
residue of the TrkB kinase domain or loss of a functional Bdnf
allele has been found to be associated with hyperphagia, severe
obesity, and impaired cognitive function in children (Yeo et al.,
2004; Gray et al., 2006). A subgroup of patients with the Wilms’
tumor, aniridia, genitourinary anomalies, and mental retardation
(WAGR) syndrome display hyperphagia and obesity (Fischbach
et al., 2005). The WAGR syndrome results from heterozygous,
variably sized, contiguous deletions on chromosome 11, which
extend into the Bdnf gene in some cases. Careful mapping of
the deletion regions in 33 patients with the WAGR syndrome
has identified haploinsufficiency of BDNF as the cause of the
accompanied obesity disorder (Han et al., 2008). Furthermore,
large-scale genome-wide association studies link a common sin-
gle nucleotide polymorphism in the Bdnf gene, rs6265, to human
obesity (Hotta et al., 2009; Thorleifsson et al., 2009), and rs6265
has been shown to be associated with human eating disorders
(Ribases et al., 2004; Gratacos et al., 2007). This polymorphism
changes the Val residue at position 66 of pre-pro-BDNF to a Met
residue and impairs activity-dependent BDNF secretion through
the regulated secretory pathway (Egan et al., 2003). Additional
evidence of a role for BDNF in obesity comes from a knock-in
mouse strain, which contains the Val66Metmutation and exhibits
increased body weight (Chen et al., 2006).
BDNF AS AN ANOREXIGENIC FACTOR
BDNF plays crucial roles in the development and maintenance
of neural circuits (Xu et al., 2000b; Huang and Reichardt, 2001;
Baydyuk et al., 2011a). Thus, obesity syndrome induced by BDNF
insufficiency could result from either diminished anorexigenic
activity of BDNF or structural defects in neural circuits that are
important for the control of energy homeostasis. The severe obe-
sity phenotype in a mouse mutant where the Bdnf gene is deleted
in many brain regions using a Cre transgene under the control
of the CaMKIIα promoter (Rios et al., 2001) has been widely
cited as evidence for BDNF as an anorexigenic factor because the
transgene starts to express Cre recombinase in the hippocampus
during the third postnatal week, after many developmental events
in the brain have already been completed (Tsien et al., 1996; Xu
et al., 2000a). However, CaMKIIα is expressed in the hypothala-
mus as early as the first postnatal week (An and Xu, unpublished
data), when many hypothalamic neurons are still sending their
axons to targets (Bouret et al., 2004), suggesting that the devel-
opment of hypothalamic neural circuits could be altered in this
conditional Bdnf knockout. Indeed, one study showed that the
projection of POMC-expressing neurons in the ARC to the DMH
was impaired in one Bdnf mutant strain (Liao et al., 2012). More
supportive evidence for BDNF as an anorexigenic factor comes
from the observation that selective deletion of the Bdnf gene in
the VMH and DMH of adult mice using Cre-expressing virus
still induced hyperphagia and increased weight gain (Unger et al.,
2007), although there is still the possibility that the Bdnf deletion
leads to degeneration of an anorexigenic neural circuit.
If BDNF is acting as a mediator of signals regulating energy
balance, its expression levels should change to reflect nutritional
status. Two-day food deprivation was found to drastically reduce
levels of Bdnf mRNA in the mouse VMH, without affecting Bdnf
gene expression in the cerebral cortex (Xu et al., 2003). This
observation not only demonstrates that BDNF is a bona fide
anorexigenic factor, but also indicates the importance of VMH
BDNF in the control of energy homeostasis. Furthermore, food
deprivation was also found to reduce BDNF protein levels in the
dorsal vagal complex (DVC) (Bariohay et al., 2005).Whether food
deprivation alters Bdnf gene expression in the DMH, LH, and
PVH remains to be determined. Melanocortin and glucose are
likely keymediators linking energy status to Bdnf gene expression
in the VMH, as administration of either a melanocortin analog
or glucose into fasted mice increased levels of Bdnf mRNA in
the VMH (Xu et al., 2003; Unger et al., 2007). The Bdnf gene is
expressed frommultiple promoters in the VMH (Tran et al., 2006;
Unger et al., 2007), and glucose regulates Bdnf gene expression in
the VMH through the exon I promoter (Unger et al., 2007). One
study reported that systemic leptin administration increased lev-
els of Bdnf mRNA and BDNF protein in the VMH (Komori et al.,
2006). Since BDNF neurons in the VMH do not express the lep-
tin receptor (Liao et al., 2012), leptin may indirectly regulate Bdnf
gene expression in the VMH.
Collectively, these studies show that BDNF levels in some brain
regions change in response to nutritional status and that postna-
tal ablation of BDNF expression leads to hyperphagia and obesity.
These biochemical and genetic findings, along with the pharma-
cological observation that icv infusion of BDNF reduces food
intake and body weight (Lapchak and Hefti, 1992; Pelleymounter
et al., 1995), strongly indicate that BDNF acutely and actively
regulates energy homeostasis. Given the crucial role of BDNF
in neuronal development, it is conceivable that developmental
defects in neural circuits also contribute to the massive obesity
observed in mice with impaired BDNF activity. Interestingly, cen-
tral infusion of BDNF was found to reverse hyperphagia and
excessive weight gain in Bdnf +/− mice (Kernie et al., 2000).
This result suggests that developmental defects in neural circuits
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relevant to feeding are not permanent in Bdnf or TrkB mutants
and could be overcome in later life by increasing BDNF activity.
ROLES OF BDNF IN THE REGULATION OF ENERGY
EXPENDITURE
A decrease in energy expenditure can lead to obesity, and one of
key forms of energy expenditure is thermogenesis. In mouse and
rat, the interscapular brown adipose tissue (IBAT) is the major
site of thermogenesis. Sympathetic inputs from the stellate gan-
glion increase the expression of uncoupling protein 1 (UCP1)
in IBAT, which allows the energy generated from β oxidation of
fatty acids to dissipate as heat in response to physiological stimuli
such as cold exposure and overeating (Cannon and Nedergaard,
2004; Clapham, 2012). Some neurons in several hypothalamic
areas, including DMH, LH, PVH, and retrochiasmatic area, are
poly-synaptically connected to IBAT, as revealed by pseudora-
bies virus retrograde tracing (Oldfield et al., 2002; Cano et al.,
2003).
Both peripheral and icv administration of BDNF were found
to increase turnover of norepinephrine and UCP1 gene expres-
sion in IBAT and to restore thermogenesis in food-deprived db/db
mice (Nonomura et al., 2001; Tsuchida et al., 2001). Direct injec-
tion of BDNF to the PVH and VMH in rats resulted in an increase
in energy expenditure and a decrease in weight gain (Wang et al.,
2007b, 2010). However, BDNF action in these two sites is not the
same, as BDNF injection to the PVH was found to increase the
expression of UCP1 in IBAT without affecting spontaneous phys-
ical activity (Wang et al., 2007b), whereas BDNF injection to the
VMH increased spontaneous physical activity without altering
UCP1 expression in IBAT (Wang et al., 2010). These pharma-
cological studies suggest that enhancing TrkB signaling in the
PVH and VMH increases energy expenditure by either directly
or indirectly modulating hypothalamic neurons that are con-
nected to IBAT and the motor system, respectively. Interestingly,
it was found that environmental enrichment increased thermoge-
nesis by inducing the appearance of cells with prototypical brown
fat morphology and high UCP1 levels in white fat tissue, and
that BDNF mediated this effect of environmental enrichment
(Cao et al., 2011). This observation suggests that endogenous
BDNF also regulates energy expenditure, although it remains
unknown if environmental enrichment affects thermogenesis in
IBAT as well.
Genetic data collected from Bdnf mouse mutants has not
painted a clear picture regarding the role of BDNF in energy
expenditure. Pair feeding was found to correct excessive weight
gain in Bdnf heterozygous mice (Coppola and Tessarollo, 2004),
mice where the Bdnf gene was selectively deleted in the DMH and
VMH (Unger et al., 2007), and mice lacking the long isoform of
Bdnf mRNA (Liao et al., 2012). These studies indicate that the
total energy expenditure in these mutants remains unchanged.
This evidence shows a dominant role of hyperphagia in the devel-
opment of obesity when BDNF signaling is impaired; however,
it is not sufficient to rule out a role for BDNF in the regulation
of energy expenditure. Bdnf heterozygous mice showed elevated
locomotor activity (Kernie et al., 2000), which may compensate
for reduced thermogenesis and/or reduced resting metabolic rate.
It is possible that BDNF derived from the short isoform of Bdnf
mRNA in a brain region other than the DMH and VMH may
regulate thermogenesis and resting metabolism.
PRODUCTION SITES OF THE BDNF PROTEIN CRUCIAL FOR
ENERGY HOMEOSTASIS
The VMH is likely a site for the synthesis of BDNF protein that
is critical for energy homeostasis. The Bdnf gene is expressed in
many neurons in the ventrolateral and dorsomedial parts of the
VMH, and its mRNA levels in this area are among the highest in
the brain (Xu et al., 2003). Food deprivation was found to selec-
tively and drastically reduce levels of Bdnf mRNA in the VMH
(Xu et al., 2003), and administration of melanocortin agonists
or glucose was able to partially reverse this reduction in Bdnf
gene expression (Xu et al., 2003; Unger et al., 2007). This obser-
vation suggests that hunger suppresses Bdnf gene expression in
the VMH, whereas feeding, which is accompanied by an increase
in melanocortin signaling and glucose levels in the brain, does
the opposite. This inference would predict that deletion of the
Bdnf gene in the VMH should lead to hyperphagia and obe-
sity. Deletion of the Bdnf gene in the VMH and DMH of adult
mice with adeno-associated virus (AAV) expressing Cre recombi-
nase indeed causedmodest hyperphagia and obesity (Unger et al.,
2007). However, this result does not completely address the role
of VMH BDNF in the control of energy homeostasis, because the
obesity phenotype in this mutant was very subtle in compari-
son to mutant mice where the Bdnf gene was deleted in many
brain regions or where TrkB was systemically down-regulated
(Rios et al., 2001; Xu et al., 2003). The subtlety of the obesity
phenotype is likely due to incomplete AAV-mediated Bdnf dele-
tion in the VMH. It may also result from the late onset of the
Bdnf deletion, which would remove the impact of BDNF defi-
ciency on neuronal development. When a Cre transgene driven
by the promoter for steroidogenic factor 1 (SF1-Cre) was used
to delete the Bdnf gene in SF1-expressing VMH neurons, the
resulting mutant mice did not display any body weight pheno-
type (Dhillon et al., 2006). Given that SF1 and BDNF are only
partially co-expressed in the VMH (Tran et al., 2003), this is
not a surprising result. Development of additional VMH-specific
Cre transgenic mice will greatly facilitate elucidation of the role
of VMH BDNF in the control of feeding behavior and body
weight.
Food deprivation also decreased levels of BDNF protein in the
rat DVC, whereas refeeding or peripheral injection of the anorex-
igenic hormones leptin or CCK increased BDNF protein levels in
this area (Bariohay et al., 2005). This observation suggests that
BDNF in the DVC may regulate food intake. However, it remains
to be determined whether BDNF in the DVC is synthesized
locally or comes from other brain regions through retrograde or
anterograde transport. If the BDNF protein is locally generated,
it would be important to investigate in which neuronal popula-
tions refeeding and anorexigenic factors act to regulate Bdnf gene
expression.
Mice in which TrkB gene expression was reduced to a quar-
ter of the normal amount, or the Bdnf gene was deleted in
CaMKIIα-expressing neurons, displayedmarkedly increased food
intake on high fat diet compared to low fat diet (Xu et al., 2003;
Cordeira et al., 2010). This observation indicates that BDNF is
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involved in hedonic feeding in response to palatable diet, in addi-
tion to its role in the homeostatic regulation of energy balance
in response to fat stores and peripheral signals of nutrient status.
This hedonic phenotype is dependent on the action of VTA-
derived BDNF in the NAc, since consumption of high fat diet
decreased Bdnf mRNAs in the VTA and deletion of the Bdnf gene
in the VTA induced hyperphagia on high fat diet but not low fat
diet (Cordeira et al., 2010).
Neurons produce two forms of Bdnf mRNA encoding the
same protein due to the presence of two alternative polyadeny-
lation sites: short 3′ UTR Bdnf mRNA and long 3′ UTR Bdnf
mRNA. One study indicates that BDNF protein regulating food
intake is translated from long 3′ UTR Bdnf mRNA, likely in den-
drites (Liao et al., 2012). This study used a mouse mutant with
multiple SV40 polyadenylation signal sequences inserted shortly
downstream of the first Bdnf polyadenylation site, such that the
long Bdnf 3′ UTR is truncated (Gorski et al., 2003; An et al.,
2008). Themutantmice were found to lack dendritic Bdnf mRNA
(An et al., 2008) and developed severe hyperphagic obesity (Liao
et al., 2012). Importantly, early viral expression of long, but not
short, 3′ UTR Bdnf mRNA in the VMH and nearby regions com-
pletely prevented these animals from developing hyperphagia and
obesity (Liao et al., 2012). It remains unknown, however, in which
specific neuronal populations BDNF is translated from long 3′
UTR Bdnf mRNA to regulate appetite.
ACTION SITES OF BDNF TO CONTROL ENERGY
HOMEOSTASIS
Not much is known about the action sites of BDNF with regard
to its role in the control of energy homeostasis. BDNF exerts
its biological effects through two receptors, TrkB and p75NTR
(Reichardt, 2006). Since mutations in the gene for TrkB, but not
p75NTR, lead to obesity in humans and mice (Lee et al., 1992;
Xu et al., 2003; Yeo et al., 2004), BDNF should act on the TrkB
receptor to mediate its effects on appetite and energy expenditure.
BDNF produced in a neuron can reach TrkB-expressing neu-
rons through four modes (DiStefano et al., 1992; von Bartheld
et al., 1996; Altar et al., 1997): being released and binding to
TrkB on the same neuron (autocrine) or neighboring neurons
(paracrine); being anterogradely transported to the axonal termi-
nals of the neuron and released to bind TrkB on targeted neurons
(anterograde); and being retrogradely transported to cell bodies
of innervating neurons following release and binding to TrkB on
innervating axonal terminals (retrograde). Because of the com-
plexity of BDNF action and the widespread expression of BDNF
and TrkB in the brain, it is a challenge to identify TrkB-expressing
neuron populations that mediate the effects of BDNF on energy
homeostasis.
Pharmacological studies have suggested several putative sites
where BDNF acts to control energy homeostasis. Direct injec-
tion of BDNF into either the PVH or the VMH of adult rats
was found to decrease food intake and increase energy expen-
diture (Wang et al., 2007a,b,c, 2010). Delivery of BDNF into
the medial NTS of the brainstem also reduced food intake and
increased thermogenesis, and these effects could be blocked with
a TrkB antagonist (Spaeth et al., 2012). It remains to be deter-
mined whether endogenous BDNF at these anatomical sites also
has similar effects on energy homeostasis. The PVH, VMH, and
NTS are complex structures and contain many distinct neuronal
populations. It is important to determine on which populations
of TrkB-expressing neurons BDNF acts to regulate energy home-
ostasis. These questions can be addressed using conditional TrkB
mouse knockouts. Once the neuronal populations are identi-
fied, researchers can focus on the mechanisms by which BDNF
modulates the function of these neurons.
In addition to the hypothalamus and the brainstem, the
mesolimbic dopamine system may be another target for BDNF
to affect food intake, especially hedonic eating. Consumption
of high fat diet was found to increase TrkB mRNA in the VTA
(Cordeira et al., 2010). Mice with impaired BDNF signaling
exhibited much more severe hyperphagia on fat-rich diet than
on low-fat diet (Xu et al., 2003; Cordeira et al., 2010). Mice
lacking BDNF synthesis in CaMKIIα-expressing neurons dis-
played hypersensitivity of the dopamine receptor D1, such that
peripheral injection of a D1 receptor agonist normalized the
hyperphagia on high-fat diet (Cordeira et al., 2010). The effect
of BDNF deficiency on the dopamine receptor D1 is likely indi-
rect, as the vast majority of TrkB-expressing neurons are striatal
medium-sized spiny neurons that express the dopamine receptor
D2 (Baydyuk et al., 2011b). This indirect effect may be a com-
pensatory response to decreased evoked release of dopamine in
the NAc and the dorsal striatum. As the VTA has been identi-
fied as an important source of BDNF contributing to regulation
of hedonic eating (Cordeira et al., 2010), it would be interesting to
determine whether BDNF acts on TrkB-expressing neurons in the
VTA or the nucleus accumbens to regulate consumption of palat-
able food. It is critical to understand the changes in the structure
and function of the neural circuitry for reward when BDNF sig-
naling is impaired, which leads to hyperphagia on high-fat diet,
since excessive intake of high fat diet is likely an important cause
of the obesity pandemic in humans.
It is worth noting that one study reported that while central
administration of TrkB agonists was anorexigenic in non-human
primates, similar to what has been observed for rodents, periph-
eral administration was orexigenic, opposite to what is observed
for rodents (Lin et al., 2008). Although the observation has to be
reproduced, this brings into question the assumption that BDNF
regulates energy balance solely through activation of central path-
ways. One possible peripheral BDNF target might be the vagal
afferents (Fox et al., 2012).
DIRECT REGULATION OF GLUCOSE HOMEOSTASIS BY BDNF
Obesity in mice with BDNF deficiency is associated with hyper-
glycemia and impaired glucose tolerance (Kernie et al., 2000; Rios
et al., 2001; Liao et al., 2012), and this glucose phenotype is at
least in part attributable to the direct action of BDNF on glucose
homeostasis. In several animal models of obesity and diabetes,
including db/db mice, diet-induced obesity mice and lethal yel-
low agouti mice, peripheral administration of BDNF has been
shown to prevent or ameliorate the diabetic and obese pheno-
types (Nakagawa et al., 2003; Yamanaka et al., 2008). In db/db
mice, BDNF could potentiate the action of insulin in periph-
eral tissues, reducing serum glucose in obese, diabetic db/db
mice (Ono et al., 1997). The requirement for insulin to mediate
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the hypoglycemic effect of peripheral BDNF was demonstrated
in streptozotocin-induced type 1 diabetic mice, which had no
reduction in blood glucose levels after BDNF treatment alone,
but showed an increased hypoglycemic action of insulin when
co-administered with BDNF (Nakagawa et al., 2000). Peripheral
BDNF administration lead to decreased fed blood glucose levels
in obese diabetic db/db mice by affecting blood glucose con-
trol, rather than food intake. BDNF administration also nor-
malized fasted blood glucose levels, possibly through reduced
hepatomegaly (Tonra et al., 1999). Even intermittent peripheral
administration of BDNF was effective at reducing blood glu-
cose levels in obese diabetic db/db mice, suggesting a long-lasting
effect of BDNF on the control of glucose metabolism (Ono et al.,
2000). The lower levels of pancreatic insulin and elevated levels
of glucagon in hyperglycemic db/db mice were restored to nor-
mal levels by BDNF treatment, with increased islet beta-cell area
in BDNF-treated mice and a reversal of the decrease in pancre-
atic secretory granules, indicating a role for peripheral BDNF in
restoring impaired pancreatic insulin production and secretion in
db/db mice (Nakagawa et al., 2000; Yamanaka et al., 2006).
CNS neurons may mediate some effects of peripheral BDNF
administration on glucose homeostasis. Chronic subcutaneous
BDNF administration in db/db mice led to increased insulin
receptor activation in the liver and insulin-stimulated PI3K activ-
ity in the liver, skeletal muscle and IBAT. However, no direct effect
of BDNF was found on cultured hepatocytes, L6 muscle cells or
3T3-L1 adipocytes, suggesting an indirect route of action. This
may possibly be through regulation of central mechanisms lead-
ing to peripheral signaling, as suggested by the observation that
centrally administered BDNF also had hypoglycemic effects, and
led to similar increases in liver insulin receptor activation and
insulin-stimulated PI3K activity (Nakagawa et al., 2000; Tsuchida
et al., 2001). Peripheral administration of BDNF increased glu-
cose uptake and norepinephrine content in muscle and IBAT of
db/db mice, indicating the activation of sympathetic pathways to
regulate glucose metabolism (Yamanaka et al., 2007). It remains
unclear how peripherally administered BDNF gets into the CNS
and which CNS neurons BDNF acts on to regulate glucose uptake
through the sympathetic nervous system.
INTERACTION OF BDNF-TrKB SIGNALINGWITH OTHER
ANOREXIGENIC FACTORS
Several studies indicate that BDNF acts downstream of anorex-
igenic factors such as leptin and CCK to regulate food intake
and body weight. Peripheral leptin administration was found to
increase Bdnf mRNA levels in the VMH (Komori et al., 2006)
and BDNF protein levels in the DVC (Bariohay et al., 2005).
Peripheral CCK injection also increased BDNF protein levels in
the DVC and hypothalamus (Bariohay et al., 2005). These effects
on BDNF protein levels likely result from increased translation
of Bdnf mRNA in dendrites, as leptin increased dendritic Bdnf
mRNA translation in cultured hypothalamic neurons (Liao et al.,
2012). In support of this argument, CCK increased BDNF pro-
tein levels in the DVC within 30min (Bariohay et al., 2005),
a duration that may be too short for regulation at the tran-
scriptional level. Leptin exerts its physiological action through
the long-form leptin receptor LepRb (Chua et al., 1996; Lee
et al., 1996). Interestingly, BDNF-expressing neurons in the DMH
and VMH do not express LepRb, but leptin administration was
found to induce expression of c-Fos in these neurons (Liao
et al., 2012). This observation indicates that leptin indirectly
stimulates synthesis of Bdnf mRNA and BDNF protein, likely
by activating BDNF-expressing neurons through a polysynaptic
neural circuit.
BDNF signaling through the TrkB receptor is necessary for
the anorexigenic action of leptin. Peripheral leptin injections
reduced food intake in wild-type mice, but failed to do so in
mice lacking long 3′ UTR Bdnf mRNA (Liao et al., 2012). Leptin
administration into the mNTS also reduced food intake, and
co-administration of a TrkB antagonist attenuated the intake-
suppressive effect of leptin (Spaeth et al., 2012). Activation of
LepRb by leptin induces phosphorylation of signal transducer and
activator of transcription protein 3 (STAT3) (Munzberg et al.,
2003). In the DMH and VMH of mice and rats, leptin activates
STAT3 and induces c-Fos expression in distinct neuronal popu-
lations (Hubschle et al., 2001; Liao et al., 2012), indicating that
LepRb-expressing neurons send inputs to non-LepRb-expressing
neurons and subsequently induce c-Fos expression in these cells.
In mice lacking long 3′ UTR Bdnf mRNA, leptin injection acti-
vated LepRb normally in the ARC, DMH, and VMH, as indicated
by phosphorylation of STAT3; however, leptin-induced c-Fos
expression was impaired in the ARC and VMH and abolished in
the DMH (Liao et al., 2012). These observations indicate that one
way by which BDNF controls energy homeostasis is to regulate
the formation, maintenance, and/or function of neuronal con-
nections. When BDNF signaling is compromised, neural circuits
in these hypothalamic areas are dysfunctional and fail to transmit
the anorexigenic signal of leptin, leading to leptin resistance and
obesity.
BDNF also interacts with the melanocortin system to regulate
energy homeostasis. The initial consideration of this interac-
tion arose from the appreciation of similar obesity phenotypes
between TrkB mutant mice and Mc4r−/− knockout mice (Xu
et al., 2003). Both mutants exhibit increased linear growth, more
severe obesity in females than in males, and extremely increased
appetite on fat-rich diet (Huszar et al., 1997; Butler et al., 2001;
Xu et al., 2003). Furthermore, BDNF infusion into the lateral
ventricle suppressed the hyperphagia and excessive weight gain
observed on fat-rich diet in agouti lethal yellow mice that overex-
press the agouti protein, an antagonist of melanocortin receptors
(Xu et al., 2003). Additional evidence for BDNF acting down-
stream of the MC4R was obtained from TrkBF616A mice in which
the phenylalanine residue at position 616 of the TrkB recep-
tor is changed to an alanine residue, which makes the TrkB
kinase sensitive to inhibition by the small molecule 1NaPP1
(Chen et al., 2005). Systemic administration of 1NaPP1 in these
mice abolished the anorexigenic effect of a selective MC4R ago-
nist (Bariohay et al., 2009). Melanocortin agonists were found
to increase Bdnf mRNA levels in the VMH (Xu et al., 2003),
to increase BDNF protein levels in the DVC (Bariohay et al.,
2009), and to stimulate BDNF release from hypothalamic slices
(Nicholson et al., 2007). Given that neuronal activity stimulates
gene expression and release of BDNF (Waterhouse and Xu, 2009),
MC4R signaling may enhance TrkB activity by either directly or
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indirectly stimulating BDNF-expressing neurons. α-MSH acts on
the MC4R mainly in the PVH and the intermediolateral cell col-
umn of the thoracic spinal cord to regulate food intake and energy
expenditure (Balthasar et al., 2005; Rossi et al., 2011), and thus
further studies are needed to investigate the interaction between
the MC4R and the BDNF-TrkB pathway in these two nuclei.
SUMMARY AND PERSPECTIVE
Strong evidence of a crucial role for BDNF in the control of energy
homeostasis has been accumulated from genetic and pharmaco-
logical studies during the last decade or so. The Val66Met poly-
morphism in the Bdnf gene is a common allele (Shimizu et al.,
2004) and has been linked to human obesity (Hotta et al., 2009;
Thorleifsson et al., 2009). It is likely that BDNF acts downstream
of many anorexigenic factors to control body weight. Thus, elu-
cidation of the mechanisms by which BDNF controls appetite
and energy expenditure should have important implications for
human health. Recent studies indicate that synaptic plasticity in
the hypothalamus plays a crucial role in its control of energy
homeostasis (Pinto et al., 2004; Yang et al., 2011; Liu et al., 2012).
Given its important role in synaptic plasticity, BDNF may reg-
ulate energy homeostasis by modulating synaptic plasticity in
relevant areas. With the availability of more and more Cre trans-
genic mice and circuitry-mapping tools, it is becoming feasible
to identify the neural circuits mediating the effects of BDNF on
energy homeostasis. Identification of these circuits and elucida-
tion of the mechanisms by which BDNF acts on them will greatly
enhance our understanding of human obesity and hopefully bring
us closer to a strategy for designing effective drug treatments for
this disease.
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